All of their patients with malignant rhabdoid tumors had negative test results for ERG, suggesting that ERG may be a useful marker to distinguish ES from malignant rhabdoid tumors with loss of INI1. This evidence concerns the gene SMARCB1 and rhabdoid tumor.